In a new study, researchers shed light on the evolutionary history of enterococci, pathogens which evolved nearly indestructible properties and have become leading causes of modern antibiotic-resistant infections in hospitals.
Antibiotic resistance is now a leading public health concern worldwide. Some microbes, often referred to as "superbugs," are resistant to virtually all antibiotics.
"By analysing the genomes and behaviours of today's enterococci, we were able to rewind the clock back to their earliest existence and piece together a picture of how these organisms were shaped into what they are today" said Ashlee M Earl, from the Broad Institute of MIT and Harvard.
The picture the researchers pieced together begins with the dawn of life. Bacteria arose nearly four billion years ago, and the planet has teemed with them ever since, including the sea.
Animals first arose in the sea during the time known as the Cambrian Explosion, 542 million years ago. As animals emerged in a sea of bacteria, bacteria learnt to live in and on them.
Since enterococci live in the intestines of most land animals, it is likely that they were also in the intestines of ones that are now extinct, including dinosaurs and the first millipede-like organisms to crawl onto land.
Comparison of the genomes of these bacteria provided evidence that this was indeed the case.
Researchers also found that new species of enterococci appeared whenever new types of animals appeared.
Sea animals excrete intestinal microbes into the ocean, which usually contains about 5,000 mostly harmless bacteria per drop of water.
Those are then eaten by fish, and the microbes continue to circulate throughout the food chain.
However, on land, intestinal microbes are excreted as feces, where they often dry out and most die over time.
However enterococci are unusually hardy and can withstand drying out and starvation.
"We now know what genes were gained by enterococci hundreds of millions of years ago, when they became resistant to drying out, and to disinfectants and antibiotics that attack their cell walls," said Michael S Gilmore, from the Harvard Infectious Disease Institute in the US.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
